Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

TAKTAK
Showing 8 of 29 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in TAKEDA PHARMACEUTICAL CO LTD

Qube Research & Technologies Ltd holds 2.2M shares of TAK (TAKEDA PHARMACEUTICAL CO LTD), worth $35.4M as of 2026-Q2. This is a new position. TAK represents 0.0% of Qube Research & Technologies Ltd's portfolio.

Current Value

$35.4M

Current Shares

2.2M

Total Value Change

+$33.5M

Total Shares Change

+2.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
2.2M
-
$35.4M0.0%$16.03
40
2026-Q1
Exited
0
-100.0%
$00.0%$18.08
0
2025-Q4
Decreased
197,507
-88.9%
$3.1M0.0%$15.63
0
2025-Q3
Increased
1.8M
+407.9%
$26M0.0%$14.62
46
2025-Q2
Increased
349,661
+19.1%
$5.4M0.0%$15.10
32
2025-Q1
Increased
293,699
+63.2%
$4.4M0.0%$14.71
39
2024-Q4
Increased
179,938
+38.3%
$2.4M0.0%$12.87
34
2024-Q3
New
130,117
-
$1.9M0.0%$13.89
36

Other major holders of TAK: BNP PARIBAS FINANCIAL MARKETS, GLENVIEW CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used